| 1 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
They used flow cytometry which is FOXA2 and OTX2. |
The table shows that using this method of analysis, more than 70% is positive for both markers. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
It has potential to improve the productivity and patient outcomes. |
It can transform medical practice and materially improve patient outcomes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
It is practical and does advanced diagnostic imaging to reduce human misdiagnoses. |
Its capability in diagnostic imaging and applicability can support radiologists in interpreting imaging data, especially when the average radiologist must interpret an image within every 3 to 4 seconds, which misdiagnosis rates are at 3 to 5 percent in daily practice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
It is the knowledge and understanding of the responsible use of AI. |
The article emphasizes on system understanding for AI acceptability. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the AI machines has no correlation to the acceptability of AI. |
It is a physical trait that does not affect how healthcare professionals view the system. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence on the acceptability can affect the perspectives and opinions of healthcare professionals. |
The social influences and ethics or cultural factors can influence whether AI is accepted. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
There are concerns of AI being a threat to replace healthcare professionals if they are implemented in healthcare. |
There are perspectives that view AI as a threat to replace healthcare professionals rather than a supporting tool. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
If AI acceptability is increased, then it is critically required for designing human-centered AI systems to achieve higher levels of AI acceptability among medical professionals. |
The human-centered system will go beyond high algorithmic performance to match with users that vary in AI understanding, ethics and safety norms. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
The ethicality of healthcare professionals affects the compatibility with AI. |
AI must be compatible with professional standards and values to be able to be accepted. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
AI acceptability needs to be modified in contexts where the user has expert knowledge and disciplinary norms. |
The user must be a healthcare professional and suggests designing human-centered AI systems. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
They used nude rats to test GLP safety. |
To assess the safety of STEM-PD cells before being brought to use clinically, nude rats were experimented on to show affects or biodistribution. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
They studied nude rats for about 9 months. |
They performed a 39-week toxicity, turmorigenicity, and biodistribution study of rats under full GLP conditions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
They used nude rats under GMP conditions. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|